APA način citiranja

Esteva, F. J., Franco, S. X., Hagan, M. K., Brewster, A. M., Somer, R. A., Williams, W., . . . Perez, A. (2013). An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer. AlphaMed Press.

Čikaški stil citiranja

Esteva, Francisco J., et al. An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer. AlphaMed Press, 2013.

MLA način citiranja

Esteva, Francisco J., et al. An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer. AlphaMed Press, 2013.